Cargando…
Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis
INTRODUCTION: Colchicine, thought to exert its effect via reduction of inflammation, has recently been studied in patients following acute coronary syndromes (ACS). We performed a meta-analysis of all available randomized controlled trials (RCTs) in this high-risk cohort, evaluating efficacy and saf...
Autores principales: | Nogic, Jason, Mehta, Ojas, Tong, David, Brown, Adam J., Layland, Jamie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986187/ https://www.ncbi.nlm.nih.gov/pubmed/36609745 http://dx.doi.org/10.1007/s40119-022-00298-y |
Ejemplares similares
-
Correction to: Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis
por: Nogic, Jason, et al.
Publicado: (2023) -
Correction to: Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis
por: Nogic, Jason, et al.
Publicado: (2023) -
Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease
por: Nidorf, Stefan M, et al.
Publicado: (2022) -
Is There a Role for Colchicine in Acute Coronary Syndromes?
por: Nidorf, Stefan M, et al.
Publicado: (2015) -
COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): Coronary Microvascular Physiology Pilot Substudy
por: Cole, Justin, et al.
Publicado: (2022)